Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 15;137(14):jcs261566.
doi: 10.1242/jcs.261566. Epub 2024 Jul 18.

TMEM16F scramblase regulates angiogenesis via endothelial intracellular signaling

Ke Zoe Shan  1 , Trieu Le  1 , Pengfei Liang  1 , Ping Dong  1 , Augustus J Lowry  1 , Polina Kremmyda  2 , Lena Claesson-Welsh  2 , Huanghe Yang  1   3
Affiliations

TMEM16F scramblase regulates angiogenesis via endothelial intracellular signaling

Ke Zoe Shan et al. J Cell Sci. .

Abstract

TMEM16F (also known as ANO6), a Ca2+-activated lipid scramblase (CaPLSase) that dynamically disrupts lipid asymmetry, plays a crucial role in various physiological and pathological processes, such as blood coagulation, neurodegeneration, cell-cell fusion and viral infection. However, the mechanisms through which it regulates these processes remain largely elusive. Using endothelial cell-mediated angiogenesis as a model, here we report a previously unknown intracellular signaling function of TMEM16F. We demonstrate that TMEM16F deficiency impairs developmental retinal angiogenesis in mice and disrupts angiogenic processes in vitro. Biochemical analyses indicate that the absence of TMEM16F enhances the plasma membrane association of activated Src kinase. This in turn increases VE-cadherin phosphorylation and downregulation, accompanied by suppressed angiogenesis. Our findings not only highlight the role of intracellular signaling by TMEM16F in endothelial cells but also open new avenues for exploring the regulatory mechanisms for membrane lipid asymmetry and their implications in disease pathogenesis.

Keywords: Angiogenesis; Endothelial cells; Scramblase; Src; TMEM16F; VE-cadherin.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare no competing or financial interests.

Update of

Similar articles

See all similar articles

Cited by

References

    1. Bentley, K. and Chakravartula, S. (2017). The temporal basis of angiogenesis. Philos. Trans. R. Soc. B Biol. Sci. 372, 20150522. 10.1098/rstb.2015.0522 - DOI - PMC - PubMed
    1. Bentley, K., Franco, C. A., Philippides, A., Blanco, R., Dierkes, M., Gebala, V., Stanchi, F., Jones, M., Aspalter, I. M., Cagna, G.et al. (2014). The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. 16, 309. 10.1038/ncb2926 - DOI - PubMed
    1. Bevers, E. M. and Williamson, P. L. (2016). Getting to the outer leaflet physiology of phosphatidylserine exposure at the plasma membrane. Physiol. Rev. 96, 605-645. 10.1152/physrev.00020.2015 - DOI - PubMed
    1. Bleibaum, F., Sommer, A., Veit, M., Rabe, B., Andra, J., Kunzelmann, K., Nehls, C., Correa, W., Gutsmann, T., Grotzinger, J.et al. (2019). ADAM10 sheddase activation is controlled by cell membrane asymmetry. J. Mol. Cell Biol. 11, 979-993. 10.1093/jmcb/mjz008 - DOI - PMC - PubMed
    1. Braga, L., Ali, H., Secco, I., Chiavacci, E., Neves, G., Goldhill, D., Penn, R., Jimenez-Guardeño, J. M., Ortega-Prieto, A. M., Bussani, R.et al. (2021). Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia. Nature 594, 88-93. 10.1038/s41586-021-03491-6 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources